Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares Outstanding
Ratios

OptimizeRx (OPRX) Cost of Revenue (2016 - 2026)

OptimizeRx's Cost of Revenue history spans 13 years, with the latest figure at $8.1 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 20.93% to $8.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $35.8 million, a 9.42% increase, with the full-year FY2025 number at $35.8 million, up 9.42% from a year prior.
  • Cost of Revenue hit $8.1 million in Q4 2025 for OptimizeRx, down from $8.6 million in the prior quarter.
  • Over the last five years, Cost of Revenue for OPRX hit a ceiling of $10.6 million in Q2 2025 and a floor of $5.0 million in Q2 2022.
  • Historically, Cost of Revenue has averaged $7.3 million across 5 years, with a median of $7.2 million in 2022.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 57.46% in 2021 and later dropped 20.93% in 2025.
  • Tracing OPRX's Cost of Revenue over 5 years: stood at $7.9 million in 2021, then dropped by 9.1% to $7.2 million in 2022, then soared by 46.22% to $10.5 million in 2023, then fell by 2.23% to $10.3 million in 2024, then decreased by 20.93% to $8.1 million in 2025.
  • Business Quant data shows Cost of Revenue for OPRX at $8.1 million in Q4 2025, $8.6 million in Q3 2025, and $10.6 million in Q2 2025.